A federal judge in Boston dismisses a shareholders lawsuit brought against InVivo Therapeutics and ex-CEO Frank Reynolds.
InVivo Therapeutics (OTC:NVIV) and its former CEO escaped a shareholders lawsuit alleging that they concealed the truth about how long a clinical trial would take.
InVivo, co-founded by Reynolds based on technology out of MIT professor Robert Langer's lab, is developing a treatment for spinal cord injury.
Help employers find you! Check out all the jobs and post your resume.
InVivo Therapeutics (OTC:NVIV) and its former CEO escaped a shareholders lawsuit alleging that they concealed the truth about how long a clinical trial would take.
InVivo, co-founded by Reynolds based on technology out of MIT professor Robert Langer's lab, is developing a treatment for spinal cord injury.
Help employers find you! Check out all the jobs and post your resume.
